Skip to main content
Fig. 7 | BMC Endocrine Disorders

Fig. 7

From: Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome

Fig. 7

Evaluation of the liver marker in the control, sham, PCOS, and PCOS + PDMSCs groups: Injection of PDMSCs significantly decreased the serum level of ALT and AST compared to the PCOS group (** p < 0.01, **** p < 0.0001). The data are shown as mean ± SD. AST: aspartate aminotransferase, ALT: alanine aminotransferase

Back to article page